Nebenwirkungen · Kovaltry
Kovaltry 250 IU powder and solvent for solution for injection Kovaltry 500 IU powder and solvent for solution for injection Kovaltry 1000 IU powder and solvent for solution for injection Kovaltry 2000 IU powder and solvent for solution for injection Kovaltry 3000 IU powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 7
HOS-220957 · Präparat HOS-216736
• The most frequently reported adverse reactions in the pooled population were pyrexia, headache and rash. • The most frequently reported adverse reactions in the PTPs were related to potential hypersensitivity reactions, including headache, pyrexia, pruritus, rash and abdominal discomfort. • The most frequently reported adverse reaction in PUPs/MTPs was FVIII inhibitor.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-08-13T10:29:00Z · SHA-256 bfae2a29881ddd5bb430f1c93cfc00a65941b398fc465e87299cfb7dd38ce520 · Passage b14b1ff9e0466d469965730f57dc027e05c35378dd87788fd7920d9875433a41 · Zeichen 4165–4574 im Abschnitt